Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative)

v3.8.0.1
Subsequent Events (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended
Dec. 31, 2018
Nov. 14, 2017
Oct. 26, 2017
Sep. 30, 2017
Sep. 30, 2016
Proceeds from Issuance of Common Stock       $ 4,376,455 $ 3,631,689
Stock options granted       31,425  
Subsequent Event [Member]          
Minimum amounts of R&D services $ 3,300,000        
Subsequent Event [Member] | 2015 Equity Incentive Plan [Member] | Long-Term Non-Qualified Option Grants [Member] | Employees And Consultants [Member]          
Stock options granted     1,100,000    
Option vesting condition description    
  1. The Company’s closing stock price is above $3 per share by December 31,2018
     
  2. The Company secures at least a $2 million investment from a commercial nuclear industry entity other than Areva NP by December 31, 2019
   
Subsequent Event [Member] | 2015 Equity Incentive Plan [Member] | Long-Term Non-Qualified Option Grants [Member] | Employees And Consultants Director [Member]          
Stock options granted     1,300,000    
Subsequent Event [Member] | 2015 Equity Incentive Plan [Member] | Short-Term Option Grants [Member] | Employees And Consultants [Member]          
Stock options granted     500,000    
Strike price     $ 1.05    
Option contractual term     10 years    
Fair market value of option     $ 0.70    
Expected term of option     5 years    
Subsequent Event [Member] | 2015 Equity Incentive Plan [Member] | Director [Member] | Long-Term Non-Qualified Option Grants [Member]          
Stock options granted     200,000    
Strike price     $ 1.05    
Description of Long-Term Non-Qualified Option Grants    

All such long-term non-qualified stock options issued in excess of the 2.9 million shares authorized under the 2015 Equity Stock Plan (which total approximately 0.5 million out of the total approximate 1.3 million options granted) were issued contingent upon shareholder approval of an increase in the number of shares available under the 2015 Equity Stock Plan (with such number of contingent options to be granted is granted pro-rata among the grantees).

    
Subsequent Event [Member] | Equity line agreement [Member] | Aspire Capital [Member]          
Common stock shares sold   200,000      
Proceeds from Issuance of Common Stock   $ 200,000